B. Riley Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

B. Riley Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,577	Closed	-$253K	–	868
2019 Q4	$253K	Buy	+5,577	New	+$237K	0.02%	673
2019 Q3	–	Sell	-5,053	Closed	-$220K	–	841
2019 Q2	$220K	Buy	+5,053	New	+$215K	0.02%	680
2019 Q1	–	Sell	-5,550	Closed	-$239K	–	766
2018 Q4	$239K	Sell	5,550 -880	-14%	-$41.1K	0.03%	517
2018 Q3	$317K	Sell	6,430 -117	-2%	-$5.06K	0.04%	478
2018 Q2	$210K	Buy	+6,547	New	+$226K	0.03%	597
2014 Q3	–	Sell	-1,485	Closed	-$136K	–	1521
2014 Q2	$136K	Buy	+1,485	New	+$113K	0.03%	599

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

B. Riley Wealth Advisors's PCRX Position: Q1 2020 in Review

B. Riley Wealth Advisors sold out of Pacira BioSciences (PCRX) in Q1 2020, closing a stake of 5,577 shares — an estimated $253K sold.

B. Riley Wealth Advisors first reported a position in PCRX in Q2 2014 and held it in 6 quarters. The position peaked at $317K in Q3 2018. 226 funds tracked by Wall St. Rank hold PCRX as of Q1 2020.

B. Riley Wealth Advisors reported no remaining Pacira BioSciences position as of Q1 2020 after selling out during the quarter.
B. Riley Wealth Advisors sold 5,577 Pacira BioSciences shares in Q1 2020, an estimated $253K.
B. Riley Wealth Advisors first reported a position in Pacira BioSciences in Q2 2014 and held it in 6 quarters.
B. Riley Wealth Advisors's Pacira BioSciences position peaked at $317K in Q3 2018.
226 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2020.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2020, filed 6 May 2020.